QIAGEN Focuses New HPV Test Ad Campaign on Real-Life Story of Woman’s Escape from Cervical Cancer

Posted on April 10th, 2008 by jquigley@zetainteractive.com

QIAGEN Focuses New HPV Test Ad Campaign on
Real-Life Story of Woman’s Escape from Cervical Cancer

Jodi McKinney, mother of five and wife of nearly 20 years, was recently diagnosed with cervical disease. Fortunately, she was able to be treated before it became cervical cancer – thanks in part to her physician’s decision to order an HPV test along with her Pap. Despite her initially normal Pap smear, the HPV test found that Jodi had a high-risk type of the human papillomavirus – the primary cause of cervical cancer. Now, Jodi, her entire family and her physician are the focus of a new television campaign launched by QIAGEN to share what Jodi learned about cervical cancer prevention with other women across America. QIAGEN is the developer of the digene® HPV Test, the only FDA-approved test for HPV.

The ad tells of the scare first experienced by Jodi, her husband Patrick and her five children, and of the happy ending that has allowed Jodi to tell her story today. It is now being broadcast in selected cities across the country. The TV ad can be viewed online as well.

Please click here to view the entire commercial featuring Jodi McKinney and her family sharing the message about the importance of HPV testing.

View the entire TV ad featuring Jodi McKinney and her family sharing the message about the importance of HPV testing.

Jodi’s Story:

The Facts about HPV:

  • HPV is a common virus that infects the skin and mucous membranes.
  • There are about 100 types of HPV. Approximately 30 of those are spread through genital contact (typically sexual intercourse). Around 13 "high-risk" types of HPV can cause cervical cancer.
  • It’s estimated that 80 percent of women will get an HPV infection by the age of 50. Although most of those infections will clear up on their own, those that persist can cause abnormal cells that develop into cervical cancer if not treated early.
  • Despite the many people it has helped, the Pap test fails to identify some women with cervical disease – like Jodi.
  • The digene HPV Test uses molecular diagnostic technology to detect the genetic “footprint” of the virus that causes abnormal cervical cells – HPV. It has been approved for use with a Pap for all women age 30 and over – who are most at risk of developing cervical cancer.
  • The new HPV vaccine does not provide complete protection, particularly for women who already have been exposed to HPV.
  • According to a recent survey from the National Association of Nurse Practitioners in Women’s Health (NPWH), many women are in the dark when it comes to cervical cancer prevention.
  • Test your HPV knowledge with a myths/facts quiz!
 
RELATED LINKS

 

    QUOTES
    “I feel so fortunate that my doctor gave me the HPV test along with my Pap. Without that extra precaution, I probably wouldn’t have found out about my condition until cancer had already developed.” – Jodi McKinney
     
    The risk of cervical cancer is real for nearly every sexually active woman, and adding the HPV test to the Pap gives physicians and women more sensitive screening, earlier detection and greater peace of mind.” – Dr. Mamie Bowers, Jodi’s gynecologist
     
    “A myth that exists about HPV and cervical cancer is that women don’t think they need the HPV test if they’ve had normal Pap smears all their lives. However, the Pap isn’t foolproof. It’s still possible to suddenly discover you have invasive cancer despite a history of normal Paps. Getting the HPV test along with your Pap if you’re over 30 – when you are most at risk — provides maximum peace of mind.” - Susan Wysocki, NP, president and CEO of the National Association of Nurse Practitioners in Women’s Health.
     
    “Jodi and her family are courageous in their willingness to share their story with the country. She puts a real, human face on the data that show that cervical cancer can strike any woman, and that combining HPV testing with the Pap can save lives.” – Linda Alexander, PhD, Vice President of Women’s Health, QIAGEN

    About QIAGEN:

    QIAGEN NV is the leading global provider of sample and assay technologies, with its global headquarters in the Netherlands. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue, and assays make these isolated molecules visible to facilitate such vital activities as biological research and detection of disease. QIAGEN has developed and markets more than 500 products as well as instruments that make their use more efficient and accurate. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN’s assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide, including the only FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer. QIAGEN employs more than 2,600 people in over 30 locations worldwide. Further information about QIAGEN can be found at www.qiagen.com.

    CONTACT INFORMATION

    Pam Rasmussen (Spokesperson)
    QIAGEN
    19300 Germantown Rd.
    Germantown, MD 20874

    (240) 686-7616 (office)
    (240) 632-7596 (fax)

    Email:
    Web site: http://www.thehpvtest.com

    Technorati Tags: | | | | | | | | | | | | | | | | | | | | | | | | | |

    Post a comment